BEPANTHEN

This brand name is authorized in Austria, Germany, Estonia, Finland, France, Israel, Lithuania, New Zealand, Poland, Turkey

Active ingredients

The drug BEPANTHEN contains one active pharmaceutical ingredient (API):

1 Dexpanthenol UNII 1O6C93RI7Z - DEXPANTHENOL

Dexpanthenol is converted in tissues to pantothenic acid, a component of coenzyme A (CoA) that is essential to normal epithelial function, increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Read about Dexpanthenol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D03AX03	Dexpanthenol	D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01578675, 01578681, 01578793, 01578818, 01578847, 01580241, 02180584
Country: EE	Ravimiamet	Identifier(s): 1000865, 1000933, 1123771, 1123782, 1164833
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 020778, 100131, 195172, 484524, 509497
Country: FR	Base de données publique des médicaments	Identifier(s): 64835212, 69170446
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 323, 5097, 5172, 5505
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012890, 1012891
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11255, 21616
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100009506
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546115198, 8699546754960, 8699546754977, 8699546755141